Literature DB >> 30407600

Insomnia and suicidal ideation in nonaffective psychosis.

Brian J Miller1, Carmen B Parker2, Mark H Rapaport3, Peter F Buckley4, William V McCall1.   

Abstract

Study
Objectives: Insomnia is a common symptom in the clinical course of schizophrenia. There is a robust association between insomnia and suicidality in other psychiatric disorders. Two previous studies found associations between insomnia and suicide attempt or completed suicide in patients with schizophrenia. We hypothesized that greater insomnia would be associated with greater levels of suicidal ideation in patients with schizophrenia and other nonaffective psychoses.
Methods: We recruited 108 inpatients and outpatients age 18-65 between July 2010 and July 2016 with DSM-IV nonaffective psychosis (schizophrenia, schizoaffective disorder, or schizophreniform disorder). We investigated relationships between current insomnia (Insomnia Severity Index [ISI]), suicidal ideation over the past week, and lifetime history of suicide attempt (Beck Scale for Suicide Ideation [BSS]) in regression analyses.
Results: After controlling for potential confounders, insomnia was a significant indicator of suicidal ideation (β = 0.27, p = 0.032). Insomnia was also a significant indicator of a high BSS score (≥16; OR = 1.14, 95% CI: 1.01-1.28, p = 0.029). Furthermore, participants with severe insomnia were almost 15 times more likely to have a lifetime history suicide attempt than participants without current insomnia (OR = 14.8, 95% CI: 1.4-157, p = 0.025). Insomnia was also an indicator of greater PANSS total (β = 0.33, p = 0.001), positive subscale (β = 0.32, p = 0.002), and general subscale (β = 0.40, p < 0.001) scores. Conclusions: Insomnia is associated with suicidal ideation, lifetime suicide attempt, and greater psychopathology in patients with schizophrenia. Our findings suggest that formal assessment of insomnia may be germane to the clinical care of patients with schizophrenia as a marker of suicide risk and symptom severity.

Entities:  

Year:  2019        PMID: 30407600      PMCID: PMC6369728          DOI: 10.1093/sleep/zsy215

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  59 in total

Review 1.  A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.

Authors:  Andrew J Bradley; Timothy G Dinan
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

Review 2.  Sleep and inflammation: psychoneuroimmunology in the context of cardiovascular disease.

Authors:  Sarosh J Motivala
Journal:  Ann Behav Med       Date:  2011-10

Review 3.  C-reactive protein levels in schizophrenia: a review and meta-analysis.

Authors:  Brian J Miller; Nick Culpepper; Mark H Rapaport
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-01

Review 4.  Sleep and circadian rhythm dysregulation in schizophrenia.

Authors:  Jaime M Monti; Ahmed S BaHammam; Seithikurippu R Pandi-Perumal; Vivien Bromundt; D Warren Spence; Daniel P Cardinali; Gregory M Brown
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-01-11       Impact factor: 5.067

Review 5.  Sleep in schizophrenia: A systematic review and meta-analysis of polysomnographic findings in case-control studies.

Authors:  Man-Sum Chan; Ka-Fai Chung; Kam-Ping Yung; Wing-Fai Yeung
Journal:  Sleep Med Rev       Date:  2016-03-10       Impact factor: 11.609

Review 6.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

7.  CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.

Authors:  Andreas Carlborg; Jussi Jokinen; Anna-Lena Nordström; Erik G Jönsson; Peter Nordström
Journal:  Schizophr Res       Date:  2009-05-01       Impact factor: 4.939

8.  Treating Sleep Problems in Patients with Schizophrenia.

Authors:  Felicity Waite; Elissa Myers; Allison G Harvey; Colin A Espie; Helen Startup; Bryony Sheaves; Daniel Freeman
Journal:  Behav Cogn Psychother       Date:  2015-07-30

9.  Clinician perceptions of sleep problems, and their treatment, in patients with non-affective psychosis.

Authors:  Aliyah Rehman; Felicity Waite; Bryony Sheaves; Stephany Biello; Daniel Freeman; Andrew Gumley
Journal:  Psychosis       Date:  2016-07-29

10.  Disrupting Sleep: The Effects of Sleep Loss on Psychotic Experiences Tested in an Experimental Study With Mediation Analysis.

Authors:  Sarah Reeve; Richard Emsley; Bryony Sheaves; Daniel Freeman
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

View more
  6 in total

1.  Insomnia and suicide as reported adverse effects of second-generation antipsychotics and mood stabilizers.

Authors:  Brian J Miller; William V McCall
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

2.  Sleep quality moderates the association between psychotic-like experiences and suicidal ideation among help-seeking university students.

Authors:  Elizabeth C Thompson; Samantha Y Jay; Nicole D Andorko; Zachary B Millman; Pamela Rakhshan Rouhakhtar; Kristin Sagun; Susan C Han; Bruce Herman; Jason Schiffman
Journal:  Psychiatry Res       Date:  2021-01-02       Impact factor: 3.222

3.  Assessing the psychometric properties of the PROMIS sleep measures in persons with psychosis.

Authors:  Christina L G Savage; Ryan D Orth; Anyela M Jacome; Melanie E Bennett; Jack J Blanchard
Journal:  Sleep       Date:  2021-11-12       Impact factor: 6.313

Review 4.  Hormone Targets for the Treatment of Sleep Disorders in Postmenopausal Women with Schizophrenia: A Narrative Review.

Authors:  Alexandre González-Rodríguez; José Haba-Rubio; Judith Usall; Mentxu Natividad; Virginia Soria; Javier Labad; José A Monreal
Journal:  Clocks Sleep       Date:  2022-02-15

5.  Genetic evidence for a potential causal relationship between insomnia symptoms and suicidal behavior: a Mendelian randomization study.

Authors:  Malik Nassan; Iyas Daghlas; John W Winkelman; Hassan S Dashti; Richa Saxena
Journal:  Neuropsychopharmacology       Date:  2022-05-10       Impact factor: 8.294

Review 6.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.